Healthcare

  The   Spinal Surgery Devices Market   accounted for US$ 10.79 billion in 2020 and is estimated to be US$ 18.02 billion by 2030 and is anticipated to register a CAGR of 5.3%. Spine surgery is one of the fast-growing surgical technique. It has progressed into one of the major divisions of the orthopedic industry. Spinal surgery is usually performed as open surgery, wherein a long incision allows a surgeon to access the spinal anatomy of a body. However, owing to the recent technological advances, the number of minimally invasive procedures has increased significantly, thereby, driving growth of the spinal surgery devices market globally. Spinal fusion, also called spondylodesis or spondylosyndesis, may be a neurosurgical or orthopedic surgical technique that joins two or more vertebrae. This procedure are often performed at any level within the spine (cervical, thoracic, or lumbar) and prevents any movement between the fused vertebrae. There are many sorts of fusion and every technique

  The report " Cancer Therapy Market ,  By Cancer Type (Breast Cancer, Prostate Cancer, Blood Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Gynecologic Cancer, and Other Cancer Types), By Treatment Type (Immunotherapy, Hormonal Therapy, Chemotherapy, Targeted Therapy, and Other Treatment Types), By End User (Cancer and Radiation Therapy Centers, Hospitals, and Specialty Clinics),  and Region - Global Forecast to 2030"  global cancer therapy market is projected to grow from US$ 66.5 billion in 2019 Certain factors that are driving the market growth include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players.  The upsurge in demand for personalized medicine and high potential of developing nations is expected to provide new opportunities for the market players in future. Key Highlights: In January 2020, Medtronic Launches Efficio

  The   Orphan Drugs Market   is estimated to be US$ 869.6 million by 2030 with a CAGR of 10.4% during the forecast period. Orphan drugs are the pharmaceutical mediators which are developed to treat rare medical conditions. Orphan drugs would not be able to earn profit because the orphan drugs are used to treat the rare diseases. It can only produce profit by the involvement of government assistant. Orphan drugs use to diagnoses and to prevent the diseases. Orphan drugs are not developed in industry, but it is generated for the public welfare. The report "   Global Orphan Drugs Market, By Drug Type (Biological and Non- Biological), By Top Selling Drugs (Revlimid, Rituxan, Copaxone, Opdivo, Keytruda, Imbruvica, Avonex, Sensipar, Soliris, and Other Top Selling Drugs), By Disease Type (Oncology, Hematology, Neurology, Cardiovascular, and Other Disease Types), By Phase (Phase I, Phase II, Phase III, and Phase IV), and By Region (North America, Europe, Asia Pacific, Latin America, and

  The report " Aptamers Market , By Type  (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application (Diagnostics, Therapeutics, and Research and Development), and Region - Global Forecast to 2030" Global aptamers market is projected to grow from US$ 205.40 million in 2019 to US$ 985.44 million by 2030. Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are the major key driving factors responsible for the growth of global aptamers market. Low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systemic evolution of ligands by exponential enrichment technology (SELEX) which boosts the global market positively. Key Highlights : In September 2018, Base Pair Biotechnologies was awarded for discovering aptamers to canine oncology biomarkers. In April 2019, Agilent and Somalogic sign agreem

  Digital Health Market   accounted for US$ 94.5 billion in 2020 and is estimated to be US$ 281.1 billion by 2030 and is anticipated to register a CAGR of 11.5%. Digital Health has a crucial role to play to improve the impact and efficiency of the modern healthcare. The digital health involves the use of new age information communication technologies that use digital, mobile, and cloud based platforms to improve the health of patients. Further the digital health offers platforms such as, telecare, telehealth, telemedicine that is beneficiary for patients to connect with healthcare provider.Further, the digital health market also reduces the costs of treatment due to personalized and precise medicine. Digital health is the convergence of the genomics and digital revolutions with health, healthcare, living and the society. Overall the digital health is used for diagnosis, treatment, consultation, and long term care services at economy of cost with greater access to the data pool.       

The report  " Smart Diapers Market , By End User (Babies and Adults) and Region - Global Forecast to 2029"  Global smart diapers market is projected to grow from US$ 616.15 million in 2020 to US$ 3303.33 million by 2030. Global smart diapers market is driven by rising adoption of smart technology across the globe. In addition, increase in number of female workers, nuclear families, and aging population are creating a positive impact on the growth of the global smart diapers market. Moreover, adoption of smart diapers in healthcare institutions, clinics, and old age homes is also fuelling growth of the global market. Nevertheless, expansion of smart diapers through online portals will help in expanding the geographical presence worldwide which indirectly creates growth opportunities for the global market. Key Highlights : In November 2018, Amazon Web Services, Inc. launched smart diapers service to help clients develop smart diapers networks without incurring the costs of crea

  Rising usage of metal sharps in surgical procedures is a major driving factor for the global sharps containers market. According to the WHO, approximately 16 billion injections are administered every year and not all sharps are disposed of safely, creating a high risk of infections. Initiatives taken by various public and private players to spread awareness about safe collection and disposal of sharps waste and improved distribution network of key manufacturers in developing countries are major factors estimated to drive the global sharps containers market The  sharps containers market  accounted for US$ 466.7 million in 2019 and is estimated to be US$ 711.1 million by 2029 and is anticipated to register a CAGR of 4.30%. The report " Sharps Containers Market, By  Product Type ( Patient Room Containers, Phlebotomy Containers, and Multipurpose Containers ) ,  By Usage Type ( Infectious & Pathological Waste, Sharps Waste, Pharmaceutical Waste, and Non-Infectious & Other Was